December 14, 2020
Bold Health, a London-based company developing digital therapeutics for gastrointestinal conditions, is backing a new University of Pennsylvania-led study that will directly compare the company's cognitive behavior therapy (CBT) app for irritable bowel syndrome (IBS) to Headspace's consumer mindfulness and meditation app.
According to a clinicaltrials.gov listing spotted by Exits & Outcomes,...
October 30, 2019
Pear Therapeutics has announced a new deal with Ironwood Pharmaceuticals that will explore the platform’s potential for patients with certain gastrointestinal (GI) conditions.
“We are excited to be partnering with Ironwood on this initiative and believe there is a compelling clinical rationale for use of [prescription digital therapeutics] in treating GI diseases,” Dr. Corey McCann, president and...
September 13, 2019
A new company out of London called Bold Health is combining digital tools and cognitive behavioral therapy with the aim of helping patients improve their gut health.
Earlier this month, the company launched its first product, Zemedy, an app targeted at treating irritable bowel syndrome symptoms through a combination of CBT, hypnotherapy exercises and stress management techniques.
“There is a...
August 6, 2019
Chicago-based metaMe Health, a startup focused on behavioral digital treatments gastrointestinal conditions, has raised $3.8 million in seed funding. LionBird Ventures led the round, which also saw contributions from Hemi Ventures and other unnamed backers.
WHAT THEY DO
The company’s lead product is Regulora, a treatment tackling the cognitive, behavioral and affective factors that can trigger...
December 13, 2018
Digital gastrointestinal health company Vivante Health has raised $6 million in Series A funding, according to an announcement. New York-based NFP Ventures and Nashville-based FCA Venture Partners participated in the round.
What they do
Headed by Livongo founder Dr. Kimon Angelides, Vivante makes a digital program for digestive health and disease called GIThrive that includes, among other tools,...
December 21, 2015
GI Logic has received FDA 510(k) clearance for a novel device that noninvasively monitors the digestive system after patients have surgery. The device, called AbStats, consists of two disposable sensors, a telemetry monitor, and a tablet app.
“Cardiology has this portable Holter monitor that can measure heart attacks in realtime, find out if someone’s having an arrhythmia, and phone up their...
February 26, 2015
Since 2010, doctors from UCLA and the University of Michigan have been working with Ironwood Pharmaceuticals on a project called My GI Health, which leverages computers and apps to improve doctor-patient communication around gastrointestinal disorders. At an ePharma Summit update session, Dr. Brennan Spiegel, a gastroenterologist formerly associated with UCLA and now working at Cedars-Sinai...